title: Rat parietal cell function after prolonged inhibition of gastric acid secretion.
abstract: Female rats were treated orally for 3 mo with omeprazole (40 and 400 mumol/kg). Both doses caused total inhibition of gastric acid secretion and recovery was parallel to that of H+-K+-ATPase activity (30-50 and 60-80% inhibition 24 h after doses, respectively). The H+-K+-ATPase activity returned to control levels within 1 wk after the last dose. Plasma gastrin levels were dose-dependently increased during treatment but reversed to control levels within 9 days after the last dose. Parallel with a general increase in corpus mucosal mass, both pepsinogen and H+-K+-ATPase total content increased. However, their tissue concentrations did not differ from control values, suggesting that neither parietal nor chief cell density are changed by omeprazole treatment and also that their growth is parallel to the general hyperplasia. In contrast, the oxyntic mucosal histamine concentration was increased, indicating an increase in the enterochromaffin-like (ECL) cell density. Maximal capacity of the mucosa to secrete acid increased in parallel with the increase in mucosal mass and total H+-K+-ATPase content. However, basal acid secretion did not differ between treatment groups. Increased capacity slowly declined toward control levels over the 70-day recovery period after withdrawal of omeprazole. These results suggest that hypergastrinemia, induced in the rat by pharmacological inhibition of gastric acid secretion, causes a hyperplasia of oxyntic mucosal cells, ECL cells growing faster than the others. The hyperplastic mucosa has an increased capacity to produce acid and is functionally normal.
authors.affiliation: Hässle Gastrointestinal Research Laboratories, Department of Biology, Mölndal, Sweden.
authors.forename: H
authors.initials: H
authors.lastname: Larsson
authors.forename: E
authors.initials: E
authors.lastname: Carlsson
authors.forename: B
authors.initials: B
authors.lastname: Ryberg
authors.forename: J
authors.initials: J
authors.lastname: Fryklund
authors.forename: B
authors.initials: B
authors.lastname: Wallmark
mesh_terms: D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D005260:Female; D005744:Gastric Acid / Q000378:metabolism*; D005753:Gastric Mucosa / Q000033:anatomy & histology / Q000201:enzymology; D005755:Gastrins / Q000097:blood; D017506:H(+)-K(+)-Exchanging ATPase; D006632:Histamine / Q000378:metabolism; D009853:Omeprazole / Q000494:pharmacology; D009929:Organ Size / Q000187:drug effects; D010295:Parietal Cells, Gastric / Q000502:physiology*; D010435:Pepsinogens / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
chemical_list: D005755:Gastrins; D010435:Pepsinogens; D006632:Histamine; D000251:Adenosine Triphosphatases; D017506:H(+)-K(+)-Exchanging ATPase; D009853:Omeprazole